This week UK healthcare charity Nuffield Trust opened a hospital in its first central London site, located within the grounds of Barts Health NHS Trust’s St Bartholomew’s Hospital site, while Cleveland Clinic last week opened a large facility in Grosvenor Place, also in central London.
HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
In light of multinational diagnostic imaging provider Affidea's recent acquisition of Brust Zentrum, a Zurich-based breast cancer care provider, we speak to CEO Giuseppe Recchi about the company's vision to create a pan-European polydiagnostic outpatient platform.
Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
No listed health care group in Europe has grown anything like as fast as Atrys Health, which now spans Spain, Portugal, Switzerland and four Latin American countries. But does its M&A strategy have any coherence? We talk to Atrys CFO Josep Maria Huch.
Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.
Imaging and radiology is hot at the moment - especially in Germany. The next five years are going to see a huge amount of consolidation according to Dirk Knüppel, CEO at EQT-backed Meine Radiologie & Blikk Holding (MRBH) and HBI 2022 panellist. HBI caught up with him to find out more about his group's plans to expand across Europe.